
This article reviews sources of excipient variability, including raw materials and processing, both of which may vary from supplier to supplier and from plant to plant for a single manufacturer.
Brian Carlin is global manager of pharmaceutical research and development at FMC-Biopolymer (Princeton, NJ).

This article reviews sources of excipient variability, including raw materials and processing, both of which may vary from supplier to supplier and from plant to plant for a single manufacturer.

This article seeks to promote dialogue among stakeholders to facilitate consensus regarding requirements for excipients.

One of the major challenges in working with excipients today is understanding, and adjusting to, complexity in materials and formulations.

Published: August 3rd 2022 | Updated:

Published: September 1st 2016 | Updated:

Published: October 2nd 2017 | Updated: